BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27294782)

  • 21. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription.
    Dey A; Nishiyama A; Karpova T; McNally J; Ozato K
    Mol Biol Cell; 2009 Dec; 20(23):4899-909. PubMed ID: 19812244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.
    Zhang W; Prakash C; Sum C; Gong Y; Li Y; Kwok JJ; Thiessen N; Pettersson S; Jones SJ; Knapp S; Yang H; Chin KC
    J Biol Chem; 2012 Dec; 287(51):43137-55. PubMed ID: 23086925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells.
    Steger DJ; Lefterova MI; Ying L; Stonestrom AJ; Schupp M; Zhuo D; Vakoc AL; Kim JE; Chen J; Lazar MA; Blobel GA; Vakoc CR
    Mol Cell Biol; 2008 Apr; 28(8):2825-39. PubMed ID: 18285465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed lineage rearranged leukaemia: pathogenesis and targeting DOT1L.
    Stein EM; Tallman MS
    Curr Opin Hematol; 2015 Mar; 22(2):92-6. PubMed ID: 25635757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.
    Kerry J; Godfrey L; Repapi E; Tapia M; Blackledge NP; Ma H; Ballabio E; O'Byrne S; Ponthan F; Heidenreich O; Roy A; Roberts I; Konopleva M; Klose RJ; Geng H; Milne TA
    Cell Rep; 2017 Jan; 18(2):482-495. PubMed ID: 28076791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective DOT1L, LSD1, and HDAC Class I Inhibitors Reduce HOXA9 Expression in MLL-AF9 Rearranged Leukemia Cells, But Dysregulate the Expression of Many Histone-Modifying Enzymes.
    Lillico R; Lawrence CK; Lakowski TM
    J Proteome Res; 2018 Aug; 17(8):2657-2667. PubMed ID: 29972300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRD4 regulates fructose-inducible lipid accumulation-related genes in the mouse liver.
    Yamada A; Honma K; Mochizuki K; Goda T
    Metabolism; 2016 Oct; 65(10):1478-88. PubMed ID: 27621183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.
    Okuda H; Stanojevic B; Kanai A; Kawamura T; Takahashi S; Matsui H; Takaori-Kondo A; Yokoyama A
    J Clin Invest; 2017 May; 127(5):1918-1931. PubMed ID: 28394257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
    J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular delivery of acetyl-histone peptides inhibits native bromodomain-chromatin interactions and impairs mitotic progression.
    Nishiyama A; Mochizuki K; Mueller F; Karpova T; McNally JG; Ozato K
    FEBS Lett; 2008 Apr; 582(10):1501-7. PubMed ID: 18396160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias.
    Yi Y; Ge S
    J Hematol Oncol; 2022 Mar; 15(1):35. PubMed ID: 35331314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrogating Histone Acetylation and BRD4 as Mitotic Bookmarks of Transcription.
    Behera V; Stonestrom AJ; Hamagami N; Hsiung CC; Keller CA; Giardine B; Sidoli S; Yuan ZF; Bhanu NV; Werner MT; Wang H; Garcia BA; Hardison RC; Blobel GA
    Cell Rep; 2019 Apr; 27(2):400-415.e5. PubMed ID: 30970245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of DOT1L in the maintenance of leukemia gene expression.
    Wang X; Chen CW; Armstrong SA
    Curr Opin Genet Dev; 2016 Feb; 36():68-72. PubMed ID: 27151433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
    Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
    J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity.
    Finley LWS; Vardhana SA; Carey BW; Alonso-Curbelo D; Koche R; Chen Y; Wen D; King B; Radler MR; Rafii S; Lowe SW; Allis CD; Thompson CB
    Nat Cell Biol; 2018 May; 20(5):565-574. PubMed ID: 29662175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emerging roles of DOT1L in leukemia and normal development.
    McLean CM; Karemaker ID; van Leeuwen F
    Leukemia; 2014 Nov; 28(11):2131-8. PubMed ID: 24854991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-cell transcriptomics defines Dot1L interacting partners and downstream target genes in the mouse molar dental pulp.
    Guzzo R; Enkhmandakh B; Becker T; Joshi P; Robson P; Vijaykumar A; Mina M; Shin DG; Bayarsaihan D
    Int J Dev Biol; 2022; 66(7-8-9):391-400. PubMed ID: 36942693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
    Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
    Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H3K79 methylation profiles define murine and human MLL-AF4 leukemias.
    Krivtsov AV; Feng Z; Lemieux ME; Faber J; Vempati S; Sinha AU; Xia X; Jesneck J; Bracken AP; Silverman LB; Kutok JL; Kung AL; Armstrong SA
    Cancer Cell; 2008 Nov; 14(5):355-68. PubMed ID: 18977325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dot1L mediated histone H3 lysine79 methylation is essential to meiosis progression in mouse oocytes.
    Wang X; Gao W; Ma X; Wang X; Song C; Huang X; Liu H
    Neuro Endocrinol Lett; 2014; 35(6):523-30. PubMed ID: 25433842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.